Scientists at NIAID’s Vaccine Research Center (VRC) report in two new studies that an experimental influenza vaccine, designed to elicit immunity against a broad range of influenza viruses, performed...

NewsDesk  @infectiousdiseasenews A new antibody discovered in the blood of some people vaccinated against or infected with influenza can recognize a broad variety of flu viruses Scientists at Scripps...

Vivaldi Biosciences, a clinical-stage biotechnology company developing advanced vaccines for seasonal and pandemic influenza, recently announced the publication of Phase 1 clinical trial results for its...

The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety and tolerability as well as its ability to induce an immune response in healthy volunteers....

One year after Senator Edward J. Markey of Massachusetts introduced the Flu Vaccine Act, he and a number of US Senators are reintroducing the bill to pay for comprehensive research for the creation of...

Oxford University, through its innovation arm Oxford University Innovation (OUI), has entered into an option agreement for a universal influenza vaccine with US-based startup Blue Water Vaccines (BWV),...

Developing a universal influenza vaccine — a vaccine that can provide durable protection for all age groups against multiple influenza strains, including those that might cause a pandemic — is...

Data may help guide development of a universal flu vaccine Scientists have identified three types of vaccine-induced antibodies that can neutralize diverse strains of influenza virus that infect humans....